Plain language summary: clinical study findings on rimegepant melt-in-mouth tablets for treating migraine attacks

This Plain Language Summary of Publication article (PLSP) from Pain Management describes a clinical study evaluating a new orally disintegrating tablet (ODT) form of rimegepant for migraine treatment. While rimegepant was already proven effective in standard capsule or tablet form, this research specifically tested the efficacy, safety, and tolerability of this quick-dissolving version that melts in the mouth within seconds.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial’ and was published in The Lancet.

Visit The Lancet using the link to read the original article.

• calcitonin gene-related peptide
• lay summary
• Migraine
• oral disintegrating tablet
• plain language summary
• rimegepant